Meperidine

Moderate to severe acute pain, procedural sedation, and treatment of postoperative shivering are clinical applications for meperidine, a synthetic opioid of the phenylpiperidine class and Schedule II controlled substance. Laboratory testing for meperidine and its primary metabolite normeperidine is performed in pain management compliance monitoring, forensic toxicology investigations, postmortem toxicology, and clinical toxicology assessments where normeperidine accumulation poses significant neurotoxicity risk including seizures. UTAK’s pain management panels contain meperidine in urine and whole blood matrices at multiple concentration levels, supporting both screening and mass spectrometry confirmation methods. Stock and custom QC solutions can incorporate related opioids such as fentanyl, hydrocodone, hydromorphone, morphine, oxycodone, oxymorphone, methadone, buprenorphine, tramadol, tapentadol, and other commonly monitored analytes to address your laboratory’s comprehensive pain management testing requirements.